成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook Chinese Germany Japanese Korean

云飛揚(yáng)藥業(yè)(深圳)有限公司 Company Information

Company Name:    Yunfei Pharmaceutical(Shenzhen) Co., Ltd.
Tel:    0755-61160828
Email:    hulixiu@yunfeipharma.com
Nationality:    China
WebSite:    http://www.yunfeipharma.com/
Product List:    249
1 2 3

Product List
Mupirocin calcium 115074-43-6
Mupirocin 12650-69-0
Sodium fusidate 751-94-0
(1R,2S,5S)-6,6-DIMETHYL-3-AZA-BICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID METHYL ESTER HYDROCHLORIDE 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate 328086-60-8
Ritonavir 155213-67-5
Upadacitinib 1310726-60-3
Vonoprazan Fumarate 881681-01-2
Dehydronandrolon 2590-41-2
1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)- 881674-56-2
4-isothiocyanato 2-(trifluoromethyl)benzonitrile 143782-23-4
Lopinavir 192725-17-0
Abemaciclib Mesylate 1231930-82-7
Bosutinib Monohydrate 918639-08-4
Semaglutide 910463-68-2
Niraparib tosylate monohydrate 1613220-15-7
Benztropine mesylate 132-17-2
Dabrafenib Mesylate 1195768-06-9
Coenzyme Q10 303-98-0
203787-91-1
Ruxolitinib phosphate 1092939-17-7
Avatrombopag maleate 677007-74-8
Goserelin acetate 145781-92-6
mu-conotoxin 936616-33-0
Voriconazole 137234-62-9
Ivabradine hydrochloride 148849-67-6
Dexmedetomidine hydrochloride 145108-58-3
Isavuconazonium sulfate 946075-13-4
Upadacitinib hemihydrate 2050057-56-0
Ruxolitinib 941678-49-5
Cabergoline 81409-90-7
Roflumilast 162401-32-3
Parecoxib sodium 198470-85-8
Tucatinib 937263-43-9
Escitalopram oxalate 219861-08-2
Deucravacitinib 1609392-27-9
Lasmiditan succinate 439239-92-6
Halofuginone hydrobromide 64924-67-0
Vitamin D3 67-97-0
Selumetinib sulfate 943332-08-9
Sotoracib 2296729-00-3
Rimegepant 1289023-67-1
9,10-Dihydrolysergic acid 5878-43-3
Tofogliflozin 1201913-82-7
Tirzepatide 2023788-19-2
Retatrutide 2381089-83-2
Repotrectinib 1802220-02-5
(2S,5R)-5-[(Benzyloxy)amino]piperidine-2-carboxylate ethyl oxalate 1416134-48-9
Binimetinib 606143-89-9
1 2 3

Copyright 2007©  ChemicalBook. All rights reserved.